$REGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in REGENERON PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 48 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 373.91 | 1,400 | 523,474 | 1,908 | 3.3 K to 1.9 K (-42.32 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 372.75 | 1,015 | 378,341 | 3,308 | 4.3 K to 3.3 K (-23.48 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 273.67 | 4,000 | 1,094,680 | 4,323 | 323 to 4.3 K (+1,238.39 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Grant | A | 0.00 | 5,000 | 0 | 24,973 | 20 K to 25 K (+25.03 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Landry Robert E | EVP Finance CFO | Grant | A | 0.00 | 2,625 | 0 | 19,973 | 17.3 K to 20 K (+15.13 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 5,000 | 0 | 28,251 | 23.3 K to 28.3 K (+21.50 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Grant | A | 0.00 | 2,625 | 0 | 23,251 | 20.6 K to 23.3 K (+12.73 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 0.00 | 25,155 | 0 | 25,155 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 372.46 | 81,278 | 30,272,804 | 81,278 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 21.25 | 187,500 | 3,984,375 | 0 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 21.25 | 124,900 | 2,654,125 | 187,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.16 | 97,209 | 36,663,346 | 474,499 | 571.7 K to 474.5 K (-17.00 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 21.25 | 187,500 | 3,984,375 | 571,708 | 384.2 K to 571.7 K (+48.80 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.16 | 64,754 | 24,422,619 | 384,208 | 449 K to 384.2 K (-14.42 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 21.25 | 124,900 | 2,654,125 | 448,962 | 324.1 K to 449 K (+38.54 %) |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 372.46 | 24,500 | 9,125,270 | 24,500 | |
Dec 13 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Grant | A | 0.00 | 2,625 | 0 | 11,380 | 8.8 K to 11.4 K (+29.98 %) |
Dec 02 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 1,000 | 33,420 | 2,000 | |
Dec 02 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 370.00 | 1,000 | 370,000 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Dec 02 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 1,000 | 33,420 | 11,323 | 10.3 K to 11.3 K (+9.69 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 10,000 | 520,300 | 88,079 | |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 365.41 | 300 | 109,623 | 22,455 | 22.8 K to 22.5 K (-1.32 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 364.20 | 2,284 | 831,833 | 22,755 | 25 K to 22.8 K (-9.12 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 363.58 | 1,422 | 517,011 | 25,039 | 26.5 K to 25 K (-5.37 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 362.75 | 5,994 | 2,174,324 | 26,461 | 32.5 K to 26.5 K (-18.47 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 10,000 | 520,300 | 32,455 | 22.5 K to 32.5 K (+44.53 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.25 | 46,138 | 980,433 | 107,655 | |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 764 | 0 | 144,897 | 145.7 K to 144.9 K (-0.52 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 669 | 0 | 145,661 | 146.3 K to 145.7 K (-0.46 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 366.63 | 4,517 | 1,656,068 | 304,485 | 309 K to 304.5 K (-1.46 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 365.25 | 3,269 | 1,194,002 | 309,002 | 312.3 K to 309 K (-1.05 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 364.55 | 3,755 | 1,368,885 | 312,271 | 316 K to 312.3 K (-1.19 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 363.53 | 3,605 | 1,310,526 | 316,026 | 319.6 K to 316 K (-1.13 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 362.61 | 2,284 | 828,201 | 319,631 | 321.9 K to 319.6 K (-0.71 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 361.46 | 2,492 | 900,758 | 321,915 | 324.4 K to 321.9 K (-0.77 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 360.37 | 592 | 213,339 | 324,407 | 325 K to 324.4 K (-0.18 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 359.46 | 1,479 | 531,641 | 324,999 | 326.5 K to 325 K (-0.45 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 358.92 | 156 | 55,992 | 326,478 | 326.6 K to 326.5 K (-0.05 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 22,093 | 0 | 326,634 | 348.7 K to 326.6 K (-6.34 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 14,000 | 0 | 348,727 | 362.7 K to 348.7 K (-3.86 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 358.33 | 23,989 | 8,595,978 | 362,727 | 386.7 K to 362.7 K (-6.20 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.25 | 46,138 | 980,433 | 386,716 | 340.6 K to 386.7 K (+13.55 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 7,246 | 0 | 340,578 | 347.8 K to 340.6 K (-2.08 %) |
Nov 26 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 40,681 | 0 | 347,824 | 388.5 K to 347.8 K (-10.47 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 1,000 | 33,420 | 3,000 | |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 1,000 | 33,420 | 4,000 | |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 360.00 | 1,000 | 360,000 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 1,000 | 33,420 | 11,323 | 10.3 K to 11.3 K (+9.69 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 350.00 | 1,000 | 350,000 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Nov 22 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 1,000 | 33,420 | 11,323 | 10.3 K to 11.3 K (+9.69 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 273.67 | 4,500 | 1,231,515 | 6,250 | |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Gift | G | 0.00 | 1,000 | 0 | 11,349 | 12.3 K to 11.3 K (-8.10 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 349.00 | 4,500 | 1,570,500 | 323 | 4.8 K to 323 (-93.30 %) |
Nov 13 2019 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 273.67 | 4,500 | 1,231,515 | 4,823 | 323 to 4.8 K (+1,393.19 %) |
Nov 08 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 340.44 | 1,000 | 340,440 | 10,323 | 11.3 K to 10.3 K (-8.83 %) |
Sep 12 2019 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 281.15 | 172,904 | 48,611,804 | 20,550,813 | 20.7 M to 20.6 M (-0.83 %) | |
May 29 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | M | 21.25 | 153,792 | 3,268,080 | 153,793 | |
May 29 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 514 | 0 | 146,330 | 146.8 K to 146.3 K (-0.35 %) |
May 29 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 569 | 0 | 146,844 | 147.4 K to 146.8 K (-0.39 %) |
May 29 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Payment of Exercise | F | 313.64 | 80,164 | 25,142,637 | 388,505 | 468.7 K to 388.5 K (-17.10 %) |
May 29 2019 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Buy | M | 21.25 | 153,792 | 3,268,080 | 468,669 | 314.9 K to 468.7 K (+48.84 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 305.93 | 1,000 | 305,930 | 11,323 | 12.3 K to 11.3 K (-8.11 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 305.93 | 1,000 | 305,930 | 11,323 | 12.3 K to 11.3 K (-8.11 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 25,000 | 1,300,750 | 98,079 | |
May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 306.37 | 3,278 | 1,004,281 | 22,450 | 25.7 K to 22.5 K (-12.74 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 305.43 | 6,575 | 2,008,202 | 25,728 | 32.3 K to 25.7 K (-20.35 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 304.20 | 15,147 | 4,607,717 | 32,303 | 47.5 K to 32.3 K (-31.92 %) |
May 15 2019 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 25,000 | 1,300,750 | 47,450 | 22.5 K to 47.5 K (+111.36 %) |
Apr 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 21.25 | 350 | 7,438 | 0 | |
Apr 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 350 | 0 | 1,897 | 1.5 K to 1.9 K (+22.62 %) |
Apr 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 350 | 0 | 7,096 | 7.4 K to 7.1 K (-4.70 %) |
Apr 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 21.25 | 350 | 7,438 | 7,446 | 7.1 K to 7.4 K (+4.93 %) |
Mar 12 2019 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 412.17 | 131,115 | 54,041,316 | 20,723,717 | 20.9 M to 20.7 M (-0.63 %) | |
Jan 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 21.25 | 150 | 3,188 | 350 | |
Jan 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 150 | 0 | 1,547 | 1.4 K to 1.5 K (+10.74 %) |
Jan 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Gift | G | 0.00 | 150 | 0 | 7,096 | 7.2 K to 7.1 K (-2.07 %) |
Jan 18 2019 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 21.25 | 150 | 3,188 | 7,246 | 7.1 K to 7.2 K (+2.11 %) |
Jan 11 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 273.67 | 1,791 | 490,143 | 0 | |
Jan 11 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 410.00 | 1,791 | 734,310 | 12,323 | 14.1 K to 12.3 K (-12.69 %) |
Jan 11 2019 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 273.67 | 1,791 | 490,143 | 14,114 | 12.3 K to 14.1 K (+14.53 %) |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 371.40 | 3,784 | 1,405,378 | 3,784 | |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Grant | A | 0.00 | 323 | 0 | 115,095 | 114.8 K to 115.1 K (+0.28 %) |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | A | 371.40 | 3,784 | 1,405,378 | 3,784 | |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Grant | A | 0.00 | 323 | 0 | 28,823 | 28.5 K to 28.8 K (+1.13 %) |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Gift | G | 0.00 | 2,500 | 0 | 28,500 | 31 K to 28.5 K (-8.06 %) |
Jan 04 2019 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Gift | G | 0.00 | 1,000 | 0 | 31,000 | 32 K to 31 K (-3.12 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 3,450 | 179,504 | 10,326 | |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 21.25 | 675 | 14,344 | 500 | |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 362.45 | 200 | 72,490 | 7,096 | 7.3 K to 7.1 K (-2.74 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 361.65 | 100 | 36,165 | 7,296 | 7.4 K to 7.3 K (-1.35 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 360.40 | 500 | 180,200 | 7,396 | 7.9 K to 7.4 K (-6.33 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 359.38 | 200 | 71,876 | 7,896 | 8.1 K to 7.9 K (-2.47 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 358.27 | 200 | 71,654 | 8,096 | 8.3 K to 8.1 K (-2.41 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 357.50 | 200 | 71,500 | 8,296 | 8.5 K to 8.3 K (-2.35 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 356.27 | 348 | 123,982 | 8,496 | 8.8 K to 8.5 K (-3.93 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 355.14 | 100 | 35,514 | 8,844 | 8.9 K to 8.8 K (-1.12 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 21.25 | 675 | 14,344 | 8,944 | 8.3 K to 8.9 K (+8.16 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 364.42 | 1,602 | 583,801 | 8,269 | 9.9 K to 8.3 K (-16.23 %) |
Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 3,450 | 179,504 | 9,871 | 6.4 K to 9.9 K (+53.73 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 94,048 | 1,580,006 | 0 | |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 150,000 | 2,520,000 | 94,048 | |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 602,594 | 483.6 K to 602.6 K (+24.61 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 0 | 119 K to 0 (-100.00 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 48,192 | 18,183,324 | 118,993 | 167.2 K to 119 K (-28.83 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 94,048 | 1,580,006 | 167,185 | 73.1 K to 167.2 K (+128.59 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 76,863 | 29,001,179 | 73,137 | 150 K to 73.1 K (-51.24 %) |
Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 150,000 | 2,520,000 | 150,000 | 0 to 150 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 381.40 | 36,273 | 13,834,522 | 36,273 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 521 | 0 | 147,413 | 147.9 K to 147.4 K (-0.35 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 382.32 | 6 | 2,294 | 2,304 | 2.3 K to 2.3 K (-0.26 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 16,161 | 0 | 314,877 | 331 K to 314.9 K (-4.88 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 19,202 | 0 | 331,038 | 350.2 K to 331 K (-5.48 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 37,209 | 0 | 350,240 | 387.4 K to 350.2 K (-9.60 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 12,500 | 0 | 387,449 | 399.9 K to 387.4 K (-3.13 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Option Exercise | A | 381.40 | 129,013 | 49,205,558 | 129,013 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,176 | 0 | 483,601 | 484.8 K to 483.6 K (-0.24 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 3,211 | 0 | 484,777 | 488 K to 484.8 K (-0.66 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 487,988 | 487.1 K to 488 K (+0.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 487,141 | 386 K to 487.1 K (+26.22 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 385,954 | 86.8 K to 386 K (+344.55 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 400,000 | 0 | 86,820 | 486.8 K to 86.8 K (-82.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 486,820 | 244.7 K to 486.8 K (+98.97 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 244,670 | 155.4 K to 244.7 K (+57.44 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 155,406 | 331.6 K to 155.4 K (-53.14 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 331,629 | 155.4 K to 331.6 K (+113.40 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 159,324 | 69.9 K to 159.3 K (+127.94 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 569,897 | 568 K to 569.9 K (+0.34 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 612,936 | 569.6 K to 612.9 K (+7.61 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 101,187 | 0 | 75,036 | 176.2 K to 75 K (-57.42 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 176,223 | 0 to 176.2 K |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 24,643 | 0 | 0 | 24.6 K to 0 (-100.00 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 299,134 | 0 | 24,643 | 323.8 K to 24.6 K (-92.39 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 176,223 | 0 | 323,777 | 500 K to 323.8 K (-35.24 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 847 | 0 | 0 | 847 to 0 (-100.00 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 242,150 | 0 | 847 | 243 K to 847 (-99.65 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,264 | 0 | 500,847 | 590.1 K to 500.8 K (-15.13 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 89,427 | 0 | 500,000 | 589.4 K to 500 K (-15.17 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 1,921 | 0 | 500,000 | 501.9 K to 500 K (-0.38 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and CSO | Gift | G | 0.00 | 43,348 | 0 | 500,000 | 543.3 K to 500 K (-7.98 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 381.40 | 129,013 | 49,205,558 | 129,013 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 16.80 | 125,000 | 2,100,000 | 0 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 16.80 | 187,500 | 3,150,000 | 125,000 | |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.31 | 64,052 | 24,167,460 | 423,962 | 488 K to 424 K (-13.13 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 16.80 | 125,000 | 2,100,000 | 488,014 | 363 K to 488 K (+34.43 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 377.31 | 96,079 | 36,251,567 | 363,014 | 459.1 K to 363 K (-20.93 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 16.80 | 187,500 | 3,150,000 | 459,093 | 271.6 K to 459.1 K (+69.04 %) |
Dec 14 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | A | 381.40 | 11,400 | 4,347,960 | 11,400 |